APPLIED GENETIC TECHNOL CORP's ticker is AGTC and the CUSIP is 03820J100. A total of 64 filers reported holding APPLIED GENETIC TECHNOL CORP in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $80,000 | -40.7% | 17,796 | -45.2% | 0.07% | -34.3% |
| Q3 2019 | $135,000 | -0.7% | 32,500 | -9.5% | 0.10% | +21.4% |
| Q2 2019 | $136,000 | -22.7% | 35,900 | -14.7% | 0.08% | +16.7% |
| Q1 2019 | $176,000 | +47.9% | 42,100 | -11.6% | 0.07% | +44.0% |
| Q4 2018 | $119,000 | -32.8% | 47,600 | +96.0% | 0.05% | -64.3% |
| Q3 2018 | $177,000 | -40.8% | 24,291 | -69.9% | 0.14% | +70.7% |
| Q2 2018 | $299,000 | -30.1% | 80,805 | -27.3% | 0.08% | +36.7% |
| Q1 2018 | $428,000 | +24.8% | 111,082 | +16.8% | 0.06% | +46.3% |
| Q4 2017 | $343,000 | -16.5% | 95,144 | -8.5% | 0.04% | -8.9% |
| Q3 2017 | $411,000 | +478.9% | 103,939 | +645.1% | 0.04% | +400.0% |
| Q2 2017 | $71,000 | – | 13,949 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 167,192 | $2,362,000 | 1.87% |
| Perceptive Advisors | 658,851 | $9,309,000 | 0.64% |
| Iguana Healthcare Management, LLC | 100,000 | $1,413,000 | 0.58% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 416,498 | $5,885,000 | 0.33% |
| TFS CAPITAL LLC | 111,937 | $1,582,000 | 0.29% |
| GLOBEFLEX CAPITAL L P | 70,554 | $997,000 | 0.27% |
| Eventide Asset Management | 279,100 | $3,944,000 | 0.24% |
| EMERALD ADVISERS, LLC | 290,784 | $4,109,000 | 0.20% |
| Spark Investment Management LLC | 133,600 | $1,887,000 | 0.18% |
| Virtus ETF Advisers LLC | 16,223 | $229,000 | 0.17% |